logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Husain Yar Khan

wayne state university
H指数:22
被引数:1,758

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Combined Use of Ziftomenib and Selinexor Is Effective in NPM1 Mutant Acute Myeloid Leukemia

Ziftomenib与Selinexor的联合使用对NPM1突变急性髓系白血病有效

BLOOD
IF23.1
2024-11-051
PRE
Dhiman, Sandhya; Uddin, Md. Hafiz; Dhillon, Vikram; Aguilar, Jeff Justin; Aboukameel, Amro; Khan, Husain; Bannoura, Sahar; Yang, Jay; Dyson, Gregory; Buck, Steven; Azmi, Asfar; Polin, Lisa; Burrows, Francis; Kessler, Linda; Maciejewski, Jaroslaw; Balasubramanian, Suresh Kumar
Next generation nuclear export blocker KPT8602 synergizes with KRASG12D inhibitor MRTX1133 resulting in improved antitumor effects against pancreatic ductal adenocarcinoma
CANCER RESEARCH
IF16.6
2024-03-220
PRE
Khan, Husain Yar; Aboukameel, Amro; Uddin, Md Hafiz; Bannoura, Sahar F.; Keffri, Khaled; Jasti, Medha; Virga, Rachael; Motorwala, Sarah; Choucair, Khalil; Hadid, Tarik; Al-Hallak, Mohammad Najeeb; Beal, Eliza; Tobon, Miguel; Beydoun, Rafic; Dyson, Greg; Kim, Steve; Nagasaka, Misako; Philip, A. Philip; El-Rayes, Basel; Chen, Herbert; Shields, Anthony; Mohammad, Ramzi; Pasche, Boris; Azmi, Asfar
KRASG12D inhibitor MRTX1133 synergizes with the next generation nuclear transport protein inhibitor eltanexor resulting in enhanced antitumor activity against pancreatic ductal adenocarcinoma

KRASG12D抑制剂MRTX1133与下一代核转运蛋白抑制剂eltanexor协同作用，增强对胰腺导管腺癌的抗肿瘤活性

CANCER RESEARCH
IF16.6
2024-01-160
PRE
Khan, Husain Y.; Aboukameel, Amro; Uddin, Md Hafiz; Al-Hallak, Mohammad Najeeb; Beal, Eliza W.; Azar, Ibrahim; Baloglu, Erkan; Beydoun, Rafic; Sukari, Ammar; Nagasaka, Misako; Mohamed, Amr; Kaseb, Ahmed; Philip, A. Philip; El-Rayes, Basel; Chen, Herbert; Shields, Anthony; Azmi, Asfar
Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model

XPO1抑制剂和吉西他滨-nab-紫杉醇联合应用在KPC胰腺癌小鼠模型中的分子分析

CLINICAL AND TRANSLATIONAL MEDICINE
IF6.8
2023-12-225
OA
Uddin, Md. Hafiz; Al-Hallak, Mohammad Najeeb; Khan, Husain Yar; Aboukameel, Amro; Li, Yiwei; Bannoura, Sahar F.; Dyson, Gregory; Kim, Seongho; Mzannar, Yosef; Azar, Ibrahim; Odisho, Tanya; Mohamed, Amr; Landesman, Yosef; Kim, Steve; Beydoun, Rafic; Mohammad, Ramzi M.; Philip, Philip A.; Shields, Anthony F.; Azmi, Asfar S.
Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers
MOLECULAR CANCER THERAPEUTICS
IF5.5
2023-09-134
OAAI
Khan, Husain Yar; Nagasaka, Misako; Aboukameel, Amro; Alkhalili, Osama; Uddin, Md. Hafiz; Bannoura, Sahar F.; Mzannar, Yousef; Azar, Ibrahim; Beal, Eliza W.; Tobon, Miguel E.; Kim, Steve H.; Beydoun, Rafic; Baloglu, Erkan; Senapedis, William; El-Rayes, Bassel F.; Philip, Philip A.; Mohammad, Ramzi M.; Shields, Anthony F.; Al Hallak, Mohammed Najeeb; Azmi, Asfar S.
Identification of key regulators for nuclear protein export inhibitor and chemotherapy combination in pancreatic cancer using spatial genomics approach
CANCER RESEARCH
IF16.6
2023-04-140
PRE
Uddin, Md. Hafiz; Bannoura, Sahar F.; Khan, Husain Y.; Aboukameel, Amro; Li, Yiwei; Azar, Ibrahim; Bael, Eliza W.; Tobon, Miguel; Weaver, Donald; Kim, Steve; Odisho, Tanya; Mohammed, Amr; Dyson, Gregory; Beydoun, Rafic; Mohammad, Ramzi M.; Chen, Herbert; El-Rayes, Bassel; Philip, A. Philip; Al-Hallak, Mohammad N.; Azmi, Asfar S.
Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study
CLINICAL CANCER RESEARCH
IF10.2
2021-03-3017
OA
Seymour, Erlene K.; Khan, Husain Yar; Li, Yiwei; Chaker, Mahmoud; Muqbil, Irfana; Aboukameel, Amro; Ramchandren, Radhakrishanan; Houde, Christiane; Sterbis, Golbon; Yang, Jay; Bhutani, Divaya; Pregja, Silvana; Reichel, Kathy; Huddlestun, Amy; Neveux, Colleen; Corona, Kelly; Landesman, Yosef; Shah, Jatin; Kauffman, Michael; Shacham, Sharon; Mohammad, Ramzi M.; Azmi, Asfar S.; Zonder, Jeffrey A.
Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma

Selinexor联合吉西他滨和Nab-紫杉醇治疗胰腺导管腺癌的临床前评估

CLINICAL CANCER RESEARCH
IF10.2
2020-03-1340
OAAI
Azmi, Asfar S.; Khan, Husain Yar; Muqbil, Irfana; Aboukameel, Amro; Neggers, Jasper E.; Daelemans, Dirk; Mahipal, Amit; Dyson, Gregory; Kamgar, Mandana; Al-Hallak, Mohammad Najeeb; Tesfaye, Anteneh; Kim, Steve; Shidham, Vinod; Mohammad, Ramzi M.; Philip, Philip A.

研究方向

暂未获取到该数据
A
Asfar S. Azmi
H 指数:65论文数:455被引数:2.0万
S
Sahar F. Bannoura
H 指数:7论文数:65被引数:338
A
Amro Aboukameel
H 指数:37论文数:281被引数:3,992
M
Md. Hafiz Uddin
H 指数:17论文数:130被引数:1,301
M
Mohammed Najeeb Al Hallak
H 指数:18论文数:159被引数:1,872
P
Philip A. Philip
H 指数:70论文数:405被引数:1.8万
R
Rafic Beydoun
H 指数:12论文数:78被引数:369
B
Bassel F. El‐Rayes
H 指数:63论文数:699被引数:1.5万
A
Aamir Ahmad
H 指数:78论文数:419被引数:1.9万
A
Ahmed Al‐Harrasi
H 指数:63论文数:1,284被引数:2.0万